GUIDANCE DOCUMENT
Characterization of Metallic Coatings and/or Calcium Phosphate Coatings on Orthopedic Devices Draft Guidance for Industry and Food and Drug Administration Staff January 2024
Not for implementation. Contains non-binding recommendations.
- Docket Number:
- FDA-2023-D-5430
- Issued by:
-
Guidance Issuing OfficeCenter for Devices and Radiological Health
This draft guidance document provides the FDA’s recommendations on information to support premarket submissions for metallic coatings and/or calcium phosphate coatings on orthopedic devices. This guidance applies to metallic coatings, calcium phosphate coatings, or metallic and calcium phosphate dual coatings on orthopedic devices. The recommendations reflect current review practices and are intended to promote consistency and facilitate efficient review of submissions for orthopedic devices which contain metallic and/or calcium phosphate coatings.
Submit Comments
You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))
If unable to submit comments online, please mail written comments to:
Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852
All written comments should be identified with this document's docket number: FDA-2023-D-5430.